loading
前日終値:
$5.55
開ける:
$5.6
24時間の取引高:
156.65K
Relative Volume:
0.37
時価総額:
$325.69M
収益:
-
当期純損益:
$-130.41M
株価収益率:
-2.3638
EPS:
-2.24
ネットキャッシュフロー:
$-67.76M
1週間 パフォーマンス:
-6.47%
1か月 パフォーマンス:
+15.09%
6か月 パフォーマンス:
-11.62%
1年 パフォーマンス:
+15.84%
1日の値動き範囲:
Value
$5.22
$5.60
1週間の範囲:
Value
$5.22
$5.985
52週間の値動き範囲:
Value
$3.5001
$12.40

Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile

Name
名前
Monte Rosa Therapeutics Inc
Name
セクター
Healthcare (1165)
Name
電話
617-949-2643
Name
住所
321 HARRISON AVENUE, BOSTON
Name
職員
134
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
GLUE's Discussions on Twitter

GLUE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GLUE
Monte Rosa Therapeutics Inc
5.295 348.76M 0 -130.41M -67.76M -2.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
467.40 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.91 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.69 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
596.85 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.19 31.54B 3.81B -644.79M -669.77M -6.24

Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-19 ダウングレード Wells Fargo Overweight → Equal Weight
2024-02-15 開始されました Wedbush Outperform
2023-01-03 アップグレード Wells Fargo Equal Weight → Overweight
2022-10-13 開始されました UBS Buy
2022-08-15 開始されました Jefferies Buy
2022-04-28 開始されました Credit Suisse Neutral
2022-02-10 開始されました Wells Fargo Equal Weight
2021-10-14 開始されました SVB Leerink Mkt Perform
すべてを表示

Monte Rosa Therapeutics Inc (GLUE) 最新ニュース

pulisher
08:21 AM

Can Monte Rosa Therapeutics Inc. Regain Lost Ground This QuarterLow Risk High Return Opportunities Identified - metal.it

08:21 AM
pulisher
06:48 AM

Will Monte Rosa Therapeutics Inc. bounce back from current supportHigh Win Rate Strategy with Stop Protection - Newser

06:48 AM
pulisher
05:40 AM

Sector ETF performance correlation with Monte Rosa Therapeutics Inc.Technical Screener for High Growth Stocks - Newser

05:40 AM
pulisher
Jul 28, 2025

Real time scanner hits for Monte Rosa Therapeutics Inc. explainedPredictive Screener for Daily Trade Watch - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Monte Rosa Therapeutics Inc. stock price move sharplyFree Stock Target Finder That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should you hold or exit Monte Rosa Therapeutics Inc. nowMonthly Long-Term Market Recap and Summary - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Sector ETF performance correlation with Monte Rosa Therapeutics Inc. Daily Entry Opportunity Forecasting Tool - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Monte Rosa Therapeutics Inc. Enters Reversal Setup in Weekly ChartsReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Real time scanner hits for Monte Rosa Therapeutics Inc. explained Chart Pattern Recognition for Profit Timing - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Monte Rosa Therapeutics Inc. stockConsistent wealth multiplication - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Monte Rosa Therapeutics Inc. generate profit in a changing economyMaximize gains with strategic stock entries - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why Monte Rosa Therapeutics Inc. stock attracts strong analyst attention Free Accurate Buy Point for Momentum Stocks - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Monte Rosa Therapeutics Inc.Consistent high-yield stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Monte Rosa Therapeutics Inc.High-return market picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Monte Rosa Therapeutics Inc. company’s balance sheetRemarkably fast returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Monte Rosa Therapeutics Inc. stock attracts strong analyst attentionFree Financial Group - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Monte Rosa Therapeutics Inc. stock performs during market volatilityFree Access to Community - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Monte Rosa Therapeutics Inc. stockOverwhelming profit margins - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

What drives Monte Rosa Therapeutics Inc. stock priceFree Trend-Following Techniques - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Monte Rosa Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Monte Rosa Therapeutics Inc. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Monte Rosa Therapeutics Announces First Subjects Dosed in - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Monte Rosa Therapeutics and the Breakthrough Potential of MRT-8102 in Inflammatory Disease Treatment - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Monte Rosa begins phase 1 trial of NEK7-targeting molecular glue degrader - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Monte Rosa begins phase 1 trial of NEK7-targeting molecular glue degrader By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

First-Ever NEK7 Degrader Enters Clinical Trials: Monte Rosa's Novel Approach Targets Multiple Inflammatory Diseases - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Monte Rosa (GLUE) Soars 13.58% in Three Days, Hits 2025 High - AInvest

Jul 18, 2025

Monte Rosa Therapeutics Inc (GLUE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$76.39
price up icon 8.67%
$37.37
price up icon 0.88%
$104.04
price up icon 2.27%
$26.77
price down icon 2.50%
$110.46
price down icon 2.07%
biotechnology ONC
$305.19
price up icon 3.74%
大文字化:     |  ボリューム (24 時間):